{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:36:33Z","timestamp":1792607793750,"version":"4.5.0"},"reference-count":52,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Reshaping the intestinal microbiota by the ingestion of fiber, such as pectin, improves alcohol-induced liver lesions in mice by modulating bacterial metabolites, including indoles, as well as bile acids (BAs). In this context, we aimed to elucidate how oral supplementation of pectin affects BA metabolism in alcohol-challenged mice receiving feces from patients with alcoholic hepatitis. Pectin reduced alcohol liver disease. This beneficial effect correlated with lower BA levels in the plasma and liver but higher levels in the caecum, suggesting that pectin stimulated BA excretion. Pectin modified the overall BA composition, favoring an augmentation in the proportion of hydrophilic forms in the liver, plasma, and gut. This effect was linked to an imbalance between hydrophobic and hydrophilic (less toxic) BAs in the gut. Pectin induced the enrichment of intestinal bacteria harboring genes that encode BA-metabolizing enzymes. The modulation of BA content by pectin inhibited farnesoid X receptor signaling in the ileum and the subsequent upregulation of Cyp7a1 in the liver. Despite an increase in BA synthesis, pectin reduced BA serum levels by promoting their intestinal excretion. In conclusion, pectin alleviates alcohol liver disease by modifying the BA cycle through effects on the intestinal microbiota and enhanced BA excretion.<\/jats:p>","DOI":"10.3390\/cells11060968","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T12:58:36Z","timestamp":1647003516000},"page":"968","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Modulation of the Bile Acid Enterohepatic Cycle by Intestinal Microbiota Alleviates Alcohol Liver Disease"],"prefix":"10.3390","volume":"11","author":[{"given":"Dragos","family":"Ciocan","sequence":"first","affiliation":[{"name":"Inserm U996, Inflammation, Microbiome and Immunosurveillance, Universit\u00e9 Paris-Saclay, 92140 Clamart, France"},{"name":"AP-HP, Hepatogastroenterology and Nutrition, H\u00f4pital Antoine-B\u00e9cl\u00e8re, 92140 Clamart, France"},{"name":"Paris Center for Microbiome Medicine (PaCeMM) FHU, 75012 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6619-910X","authenticated-orcid":false,"given":"Madeleine","family":"Spatz","sequence":"additional","affiliation":[{"name":"Inserm U996, Inflammation, Microbiome and Immunosurveillance, Universit\u00e9 Paris-Saclay, 92140 Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Trainel","sequence":"additional","affiliation":[{"name":"Inserm U996, Inflammation, Microbiome and Immunosurveillance, Universit\u00e9 Paris-Saclay, 92140 Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4866-8937","authenticated-orcid":false,"given":"K\u00e9vin","family":"Hardonni\u00e8re","sequence":"additional","affiliation":[{"name":"Inserm U996, Inflammation, Microbiome and Immunosurveillance, Universit\u00e9 Paris-Saclay, 92140 Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5997-2694","authenticated-orcid":false,"given":"S\u00e9verine","family":"Domenichini","sequence":"additional","affiliation":[{"name":"Inserm, CNRS, Institut Paris Saclay d\u2019Innovation Th\u00e9rapeutique, Universit\u00e9 Paris-Saclay, 92296 Chatenay-Malabry, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Mercier-Nom\u00e9","sequence":"additional","affiliation":[{"name":"Inserm, CNRS, Institut Paris Saclay d\u2019Innovation Th\u00e9rapeutique, Universit\u00e9 Paris-Saclay, 92296 Chatenay-Malabry, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Desmons","sequence":"additional","affiliation":[{"name":"Paris Center for Microbiome Medicine (PaCeMM) FHU, 75012 Paris, France"},{"name":"INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP. SU, H\u00f4pital Saint Antoine, D\u00e9partement de M\u00e9tabobolomique Clinique, Sorbonne Universit\u00e9, 75012 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydie","family":"Humbert","sequence":"additional","affiliation":[{"name":"INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP. SU, H\u00f4pital Saint Antoine, D\u00e9partement de M\u00e9tabobolomique Clinique, Sorbonne Universit\u00e9, 75012 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylv\u00e8re","family":"Durand","sequence":"additional","affiliation":[{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, 94800 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9334-4405","authenticated-orcid":false,"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, 94800 Villejuif, France"},{"name":"Centre de Recherche des Cordeliers, INSERM, U1138, Equipe 11 Labellis\u00e9e par la Ligue Nationale Contre le Cancer, 75005 Paris, France"},{"name":"Universit\u00e9 Paris Descartes\/Paris V, Sorbonne Paris Cit\u00e9, 75005 Paris, France"},{"name":"Universit\u00e9 Pierre et Marie Curie, 75006 Paris, France"},{"name":"P\u00f4le de Biologie, H\u00f4pital Europ\u00e9en Georges Pompidou, AP-HP, 75015 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonin","family":"Lamazi\u00e8re","sequence":"additional","affiliation":[{"name":"Paris Center for Microbiome Medicine (PaCeMM) FHU, 75012 Paris, France"},{"name":"INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP. SU, H\u00f4pital Saint Antoine, D\u00e9partement de M\u00e9tabobolomique Clinique, Sorbonne Universit\u00e9, 75012 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Hugot","sequence":"additional","affiliation":[{"name":"Inserm U996, Inflammation, Microbiome and Immunosurveillance, Universit\u00e9 Paris-Saclay, 92140 Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Perlemuter","sequence":"additional","affiliation":[{"name":"Inserm U996, Inflammation, Microbiome and Immunosurveillance, Universit\u00e9 Paris-Saclay, 92140 Clamart, France"},{"name":"AP-HP, Hepatogastroenterology and Nutrition, H\u00f4pital Antoine-B\u00e9cl\u00e8re, 92140 Clamart, France"},{"name":"Paris Center for Microbiome Medicine (PaCeMM) FHU, 75012 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1813-5128","authenticated-orcid":false,"given":"Anne-Marie","family":"Cassard","sequence":"additional","affiliation":[{"name":"Inserm U996, Inflammation, Microbiome and Immunosurveillance, Universit\u00e9 Paris-Saclay, 92140 Clamart, France"},{"name":"Paris Center for Microbiome Medicine (PaCeMM) FHU, 75012 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2021.7683","article-title":"Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review","volume":"326","author":"Singal","year":"2021","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2018). EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J. Hepatol., 69, 154\u2013181.","DOI":"10.1016\/j.jhep.2018.03.018"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","article-title":"Alcohol, liver disease and the gut microbiota","volume":"16","author":"Bajaj","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","article-title":"Sex and gender: Modifiers of health, disease, and medicine","volume":"396","author":"Barnes","year":"2020","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Muthiah, M.D., Smirnova, E., Puri, P., Chalasani, N., Shah, V.H., Kiani, C., Taylor, S., Mirshahi, F., and Sanyal, A.J. (2022). Development of Alcohol-Associated Hepatitis Is Associated With Specific Changes in Gut-Modified Bile Acids. Hepatol. Commun.","DOI":"10.1002\/hep4.1885"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism","volume":"24","author":"Wahlstrom","year":"2016","journal-title":"Cell Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","volume":"7","author":"Thomas","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease","volume":"152","author":"Tailleux","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial","volume":"385","author":"Loomba","year":"2015","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbrc.2013.11.057","article-title":"Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease","volume":"443","author":"Wu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/hep.29676","article-title":"Modulation of the intestinal bile acid\/farnesoid X receptor\/fibroblast growth factor 15 axis improves alcoholic liver disease in mice","volume":"67","author":"Hartmann","year":"2018","journal-title":"Hepatology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/liv.14427","article-title":"Hepatoprotective impact of the bile acid receptor TGR5","volume":"40","author":"Merlen","year":"2020","journal-title":"Liver Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"100230","DOI":"10.1016\/j.jhepr.2021.100230","article-title":"Bile acid-receptor TGR5 deficiency worsens liver injury in alcohol-fed mice by inducing intestinal microbiota dysbiosis","volume":"3","author":"Spatz","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/apt.14949","article-title":"Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis","volume":"48","author":"Ciocan","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/hep4.1020","article-title":"Gut microbial composition can differentially regulate bile acid synthesis in humanized mice","volume":"1","author":"Kang","year":"2017","journal-title":"Hepatol. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","article-title":"Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease","volume":"65","author":"Llopis","year":"2016","journal-title":"Gut"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/j.gastro.2020.10.056","article-title":"Chronic Liver Diseases and the Microbiome-Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease","volume":"160","author":"Acharya","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jacl.2008.01.005","article-title":"Dietary agents that target gastrointestinal and hepatic handling of bile acids and cholesterol","volume":"2","author":"Jones","year":"2008","journal-title":"J. Clin. Lipidol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1136\/gutjnl-2020-321565","article-title":"Microbiota tryptophan metabolism induces aryl hydrocarbon receptor activation and improves alcohol-induced liver injury","volume":"70","author":"Wrzosek","year":"2021","journal-title":"Gut"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0955-2863(03)00080-9","article-title":"Intestinal steroids in rats are influenced by the structural parameters of pectin","volume":"15","author":"Dongowski","year":"2004","journal-title":"J. Nutr. Biochem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1039\/c0fo00080a","article-title":"Mechanisms underlying the cholesterol-lowering properties of soluble dietary fibre polysaccharides","volume":"1","author":"Gunness","year":"2010","journal-title":"Food Funct."},{"key":"ref_23","first-page":"1090","article-title":"Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: A double blind randomized clinical trial","volume":"15","author":"Aller","year":"2011","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nprot.2013.032","article-title":"Mouse model of chronic and binge ethanol feeding (the NIAAA model)","volume":"8","author":"Bertola","year":"2013","journal-title":"Nat. Protoc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1038\/s41598-018-25300-3","article-title":"Transplantation of human microbiota into conventional mice durably reshapes the gut microbiota","volume":"8","author":"Wrzosek","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jchromb.2012.05.015","article-title":"Bile acid profiling in human biological samples: Comparison of extraction procedures and application to normal and cholestatic patients","volume":"899","author":"Humbert","year":"2012","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed Life Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jhep.2016.11.008","article-title":"Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice","volume":"66","author":"Ferrere","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nbt.2676","article-title":"Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences","volume":"31","author":"Langille","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","article-title":"Consequences of bile salt biotransformations by intestinal bacteria","volume":"7","author":"Ridlon","year":"2016","journal-title":"Gut Microbes"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.cmet.2015.07.002","article-title":"The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity","volume":"22","author":"Broeders","year":"2015","journal-title":"Cell Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"43474","DOI":"10.1038\/srep43474","article-title":"Chronic alcohol consumption decreases brown adipose tissue mass and disrupts thermoregulation: A possible role for altered retinoid signaling","volume":"7","author":"Blaner","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1172\/JCI124376","article-title":"Brown fat activation mitigates alcohol-induced liver steatosis and injury in mice","volume":"129","author":"Shen","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep4.1256","article-title":"FXR and TGR5 Agonists Ameliorate Liver Injury, Steatosis, and Inflammation After Binge or Prolonged Alcohol Feeding in Mice","volume":"2","author":"Calenda","year":"2018","journal-title":"Hepatol. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/hep.23831","article-title":"Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism","volume":"52","author":"Brufau","year":"2010","journal-title":"Hepatology"},{"key":"ref_35","unstructured":"Feingold, K.R., Anawalt, B., Boyce, A., Chrousos, G., de Herder, W.W., Dhatariya, K., Dungan, K., Grossman, A., Hershman, J.M., and Hofland, J. (2000). Cholesterol Lowering Drugs. Endotext, MDText.com, Inc."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4158\/EP10129.OR","article-title":"Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: A randomized, prospective study","volume":"16","author":"Handelsman","year":"2010","journal-title":"Endocr. Pract."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Cabre, N., Duan, Y., Llorente, C., Conrad, M., Stern, P., Yamashita, D., and Schnabl, B. (2021). Colesevelam Reduces Ethanol-Induced Liver Steatosis in Humanized Gnotobiotic Mice. Cells, 10.","DOI":"10.3390\/cells10061496"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Hartmann, P., Duan, Y., Miyamoto, Y., Demir, M., Lang, S., Hasa, E., Stern, P., Yamashita, D., Conrad, M., and Eckmann, L. (Hepatol. Int., 2022). Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice, Hepatol. Int., Online ahead of print.","DOI":"10.1007\/s12072-022-10296-w"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/0091270009349378","article-title":"Effect of the bile acid sequestrant colesevelam on the pharmacokinetics of pioglitazone, repaglinide, estrogen estradiol, norethindrone, levothyroxine, and glyburide","volume":"50","author":"Brown","year":"2010","journal-title":"J. Clin. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.crohns.2014.05.009","article-title":"Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn\u2019s disease: A randomized, double-blind, placebo-controlled study","volume":"8","author":"Beigel","year":"2014","journal-title":"J. Crohns Colitis"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3810\/pgm.2014.05.2762","article-title":"Expanded colesevelam administration options with oral suspension formulation for patients with diabetes and hypercholesterolemia","volume":"126","author":"Finckenor","year":"2014","journal-title":"Postgrad. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/hep.23821","article-title":"The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: Results of a double-blind, randomized, placebo-controlled trial","volume":"52","author":"Kuiper","year":"2010","journal-title":"Hepatology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.25731","article-title":"Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial","volume":"56","author":"Le","year":"2012","journal-title":"Hepatology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/cvr\/cvz253","article-title":"Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidaemia and atherosclerosis development","volume":"116","author":"Zhou","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/alcalc\/agaa005","article-title":"Chronic Alcohol Consumption Increased Bile Acid Levels in Enterohepatic Circulation and Reduced Efficacy of Irinotecan","volume":"55","author":"Gong","year":"2020","journal-title":"Alcohol Alcohol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1074\/jbc.M109326200","article-title":"Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor","volume":"277","author":"Kast","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_47","first-page":"407","article-title":"Intestinal bile acid transport: Biology, physiology, and pathophysiology","volume":"32","author":"Shneider","year":"2001","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/acer.14619","article-title":"Gut-restricted apical sodium-dependent bile acid transporter inhibitor attenuates alcohol-induced liver steatosis and injury in mice","volume":"45","author":"Matye","year":"2021","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11745-017-4258-x","article-title":"Pectin Penta-Oligogalacturonide Suppresses Intestinal Bile Acids Absorption and Downregulates the FXR-FGF15 Axis in High-Cholesterol Fed Mice","volume":"52","author":"Zhu","year":"2017","journal-title":"Lipids"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/acer.13498","article-title":"Continued Alcohol Misuse in Human Cirrhosis is Associated with an Impaired Gut-Liver Axis","volume":"41","author":"Bajaj","year":"2017","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0016-5085(98)70377-4","article-title":"Role of cytokines in ethanol-induced cytotoxicity in vitro in Hep G2 cells","volume":"115","author":"Neuman","year":"1998","journal-title":"Gastroenterology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature04330","article-title":"Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation","volume":"439","author":"Watanabe","year":"2006","journal-title":"Nature"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/6\/968\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:35:02Z","timestamp":1760135702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/6\/968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,11]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["cells11060968"],"URL":"https:\/\/doi.org\/10.3390\/cells11060968","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,11]]}}}